This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davies, T. A.
Right arrow Articles by Appelbaum, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davies, T. A.
Right arrow Articles by Appelbaum, P. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2000, p. 1894-1899, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Antipneumococcal Activity of ABT-773 Compared to Those of 10 Other Agents

Todd A. Davies,1 Lois M. Ednie,1 Dianne M. Hoellman,1 Glenn A. Pankuch,1 Michael R. Jacobs,2 and Peter C. Appelbaum1,*

Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 and Department of Pathology, Case Western Reserve University, Cleveland, Ohio 441062

Received 9 March 2000/Returned for modification 11 April 2000/Accepted 27 April 2000

MICs, time-kills, and postantibiotic effects (PAEs) of ABT-773 (a new ketolide) and 10 other agents were determined against 226 pneumococci. Against 78 ermB- and 44 mefE-containing strains, ABT-773 MICs at which 50% of the isolates tested were inhibited (MIC50s) and MIC90s were 0.016 to 0.03 and 0.125 µg/ml, respectively. Clindamycin was active only against macrolide-resistant strains containing mefE (MIC50, 0.06 µg/ml; MIC90, 0.125 µg/ml). Activities of pristinamycin (MIC90, 0.5 µg/ml) and vancomycin (MIC90, 0.25 µg/ml) were unaffected by macrolide or penicillin resistance, while beta -lactam MICs rose with those of penicillin G. Against 19 strains with L4 ribosomal protein mutations and two strains with mutations in domain V of 23S rRNA, ABT-773 MICs were 0.03 to 0.25 µg/ml, while macrolide and azalide MICs were all >= 16.0 µg/ml. ABT-773 was bactericidal at twice the MIC after 24 h for 8 of 12 strains (including three strains with erythromycin MICs greater than or equal to 64.0 µg/ml). Kill kinetics of erythromycin, azithromycin, clarithromycin, and roxithromycin against macrolide-susceptible strains were slower than those of ABT-773. ABT-773 had longer PAEs than macrolides, azithromycin, clindamycin, or beta -lactams, including against ermB-containing strains. ABT-773, therefore, shows promising in vitro activity against macrolide-susceptible as well as -resistant pneumococci.

* Corresponding author. Mailing address: Department of Pathology, Hershey Medical Center, P.O. Box 850, Hershey, PA 17033. Phone: (717) 531-5113. Fax: (717) 531-7953. E-mail: pappelbaum{at}psghs.edu.

Antimicrobial Agents and Chemotherapy, July 2000, p. 1894-1899, Vol. 44, No. 7
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Smith, K., Ednie, L. M., Appelbaum, P. C., Hawser, S., Lociuro, S. (2008). Antistreptococcal Activity of AR-709 Compared to That of Other Agents. Antimicrob. Agents Chemother. 52: 2279-2282 [Abstract] [Full Text]  
  • Azoulay-Dupuis, E., Mohler, J., Bedos, J. P., Barau, C., Fantin, B. (2006). Efficacy of Cethromycin, a New Ketolide, against Streptococcus pneumoniae Susceptible or Resistant to Erythromycin in a Murine Pneumonia Model.. Antimicrob. Agents Chemother. 50: 3033-3038 [Abstract] [Full Text]  
  • Kosowska-Shick, K., Credito, K., Pankuch, G. A., Lin, G., Bozdogan, B., McGhee, P., Dewasse, B., Choi, D.-R., Ryu, J. M., Appelbaum, P. C. (2006). Antipneumococcal Activity of DW-224a, a New Quinolone, Compared to Those of Eight Other Agents.. Antimicrob. Agents Chemother. 50: 2064-2071 [Abstract] [Full Text]  
  • Kasbekar, N., Acharya, P. S. (2005). Telithromycin: The first ketolide for the treatment of respiratory infections. Am J Health Syst Pharm 62: 905-916 [Abstract] [Full Text]  
  • Matic, V., Kosowska, K., Bozdogan, B., Kelly, L. M., Smith, K., Ednie, L. M., Lin, G., Credito, K. L., Clark, C. L., McGhee, P., Pankuch, G. A., Jacobs, M. R., Appelbaum, P. C. (2004). Antipneumococcal Activities of Two Novel Macrolides, GW 773546 and GW 708408, Compared with Those of Erythromycin, Azithromycin, Clarithromycin, Clindamycin, and Telithromycin. Antimicrob. Agents Chemother. 48: 4103-4112 [Abstract] [Full Text]  
  • Reinert, R. R. (2004). Clinical efficacy of ketolides in the treatment of respiratory tract infections. J Antimicrob Chemother 53: 918-927 [Abstract] [Full Text]  
  • Bingen, E., Doit, C., Bidet, P., Brahimi, N., Deforche, D. (2004). Telithromycin Susceptibility and Genomic Diversity of Macrolide-Resistant Serotype III Group B Streptococci Isolated in Perinatal Infections. Antimicrob. Agents Chemother. 48: 677-680 [Abstract] [Full Text]  
  • Bingen, E., Doit, C., Loukil, C., Brahimi, N., Bidet, P., Deforche, D., Geslin, P. (2003). Activity of Telithromycin against Penicillin-Resistant Streptococcus pneumoniae Isolates Recovered from French Children with Invasive and Noninvasive Infections. Antimicrob. Agents Chemother. 47: 2345-2347 [Abstract] [Full Text]  
  • Neuhauser, M. M., Prause, J. L., Danziger, L. H., Pendland, S. L. (2003). In Vitro Bactericidal Activities of ABT-773 against ermB Strains of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 47: 1132-1134 [Abstract] [Full Text]  
  • Mason, E. O. Jr., Lamberth, L. B., Wald, E. R., Bradley, J. S., Barson, W. J., Kaplan, S. L. (2003). In Vitro Activities of Cethromycin (ABT-773), a New Ketolide, against Streptococcus pneumoniae Strains That Are Not Susceptible to Penicillin or Macrolides. Antimicrob. Agents Chemother. 47: 166-169 [Abstract] [Full Text]  
  • Hamilton-Miller, J. M. T., Shah, S. (2002). Activity of ketolide ABT-773 (cethromycin) against erythromycin-resistant Streptococcus pneumoniae: correlation with extended MLSK phenotypes. J Antimicrob Chemother 50: 907-913 [Abstract] [Full Text]  
  • Peric, M., Lin, G., Clark, C. L., Jacobs, M. R., Appelbaum, P. C. (2002). Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents. J Antimicrob Chemother 50: 95-100 [Abstract] [Full Text]  
  • Low, D. E., de Azavedo, J., Weiss, K., Mazzulli, T., Kuhn, M., Church, D., Forward, K., Zhanel, G., Simor, A., McGeer, A. (2002). Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46: 1295-1301 [Abstract] [Full Text]  
  • Shortridge, V. D., Zhong, P., Cao, Z., Beyer, J. M., Almer, L. S., Ramer, N. C., Doktor, S. Z., Flamm, R. K. (2002). Comparison of In Vitro Activities of ABT-773 and Telithromycin against Macrolide-Susceptible and -Resistant Streptococci and Staphylococci. Antimicrob. Agents Chemother. 46: 783-786 [Abstract] [Full Text]  
  • Nagai, K., Appelbaum, P. C., Davies, T. A., Kelly, L. M., Hoellman, D. B., Andrasevic, A. T., Drukalska, L., Hryniewicz, W., Jacobs, M. R., Kolman, J., Miciuleviciene, J., Pana, M., Setchanova, L., Thege, M. K., Hupkova, H., Trupl, J., Urbaskova, P. (2002). Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries. Antimicrob. Agents Chemother. 46: 371-377 [Abstract] [Full Text]  
  • Neuhauser, M. M., Prause, J. L., Danziger, L. H., Pendland, S. L. (2001). Postantibiotic Effects of ABT-773 and Amoxicillin-Clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. Antimicrob. Agents Chemother. 45: 3613-3615 [Abstract] [Full Text]  
  • Edelstein, P. H., Higa, F., Edelstein, M. A. C. (2001). In Vitro Activity of ABT-773 against Legionella pneumophila, Its Pharmacokinetics in Guinea Pigs, and Its Use to Treat Guinea Pigs with L. pneumophila Pneumonia. Antimicrob. Agents Chemother. 45: 2685-2690 [Abstract] [Full Text]  
  • Barry, A. L., Fuchs, P. C., Brown, S. D. (2001). In Vitro Activity of the Ketolide ABT-773. Antimicrob. Agents Chemother. 45: 2922-2924 [Abstract] [Full Text]  
  • Hoban, D. J., Wierzbowski, A. K., Nichol, K., Zhanel, G. G. (2001). Macrolide-Resistant Streptococcus pneumoniae in Canada during 1998-1999: Prevalence of mef(A) and erm(B) and Susceptibilities to Ketolides. Antimicrob. Agents Chemother. 45: 2147-2150 [Abstract] [Full Text]  
  • Fitoussi, F., Doit, C., Geslin, P., Brahimi, N., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France. Antimicrob. Agents Chemother. 45: 636-638 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»